Section 6811-C - Patient notification of recalled drugs1. For purposes of this section the term "class I recall" shall mean a situation in which the United States food and drug administration deems there is reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.2. Where there has been a class I recall of a prescription drug, pharmacies shall make a reasonable attempt to notify all patients that have been prescribed and who are currently taking such recalled drug dispensed from such pharmacy by phone or by mail within three days of the pharmacy being notified by the United States food and drug administration, a manufacturer, a wholesaler or by other notice of such recall.3. The notification required by this section may be provided by an individual pharmacy or by a central office in the case of a pharmacy that is part of a chain.Added by New York Laws 2019 , ch. 379, Sec. 1, eff. 10/18/2019.